HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
133,950,846
Share change
-1,270,488
Total reported value
$3,522,042,268
Put/Call ratio
48%
Price per share
$26.28
Number of holders
262
Value change
-$34,152,841
Number of buys
116
Number of sells
124

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q3 2020

As of 30 Sep 2020, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 262 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 133,950,846 shares. The largest 10 holders included Artisan Partners Limited Partnership, BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Bellevue Group AG, JPMORGAN CHASE & CO, STATE STREET CORP, Invesco Ltd., SNYDER CAPITAL MANAGEMENT L P, and Third Security, LLC. This page lists 262 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
256
Q3 2020 holders
262
Holder diff
6
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.